Improving Blood Pressure Management in Patients With Diabetes

Summary

About 22% of Canadians have high blood pressure, or hypertension. However, studies have shown that only 1 out of 5 people with hypertension have their blood pressure controlled.

Diabetes is also an important risk factor for heart disease and stroke. About half of people with diabetes also have hypertension - a deadly combination. Studies have shown that only about 1 in 10 people with diabetes have their blood pressure controlled adequately - clearly something needs to be done to improve this.

Heart disease, stroke, hypertension, and diabetes are conditions that occur in the community, so we need to explore innovative solutions that will work in the community. Pharmacists are well-placed in the community to help identify people with diabetes and hypertension. This has worked very well in previous studies in patients with high cholesterol levels. Pharmacists and nurses have complementary skills which, when working as a team, may help identify and better manage hypertension in people with diabetes.

Our main objective is to test whether a community pharmacist and nurse team can improve blood pressure control in people with diabetes and hypertension.

Conditions

• Hypertension
• Diabetes Mellitus, Type 1
• Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Lifestyle Counselling; Opinion Leader Influence Statements

Sponsors & Collaborators

• Canadian Diabetes Association

  collaborator OTHER

• Heart and Stroke Foundation of Canada

  collaborator OTHER

• College and Association of Registered Nurses of Alberta

  collaborator OTHER

• Alberta Health & Wellness

  collaborator OTHER_GOV

• Medicine Shoppe of Canada

  collaborator UNKNOWN

• Canadian Council of Cardiovascular Nurses

  collaborator OTHER

• MED Institute, Incorporated

  collaborator INDUSTRY

• Capital Health, Canada

  collaborator OTHER

• Alberta Heritage Foundation for Medical Research

  collaborator OTHER

• Alberta Medical Association

  collaborator OTHER

• Merck Frosst Canada Ltd.

  collaborator INDUSTRY

• University of Alberta

  lead OTHER

Principal Investigators

• Ross T Tsuyuki, PharmD, MSc · University of Alberta

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2005-05-31

Completion

2007-05-31

Countries

• Canada

Study Locations